Skip to main content
. 2016 Jun 27;83:1–7. doi: 10.1016/j.curtheres.2016.06.001

Table IV.

Subject preference survey results for formulation attributes.*

Attribute Effervescent NAC tablets (n = 29) Reference oral solution NAC (n = 30) P value
Taste 0.0247
 Like very much 1 (3.4) 0
 Like 7 (24.1) 0
 Neither like nor dislike 5 (17.2) 4 (13.3)
 Dislike 7 (24.1) 20 (66.7)
 Dislike very much 9 (31.0) 6 (20.0)
Smell 0.0533
 Like very much 1 (3.4) 0
 Like 5 (17.2) 1 (3.3)
 Neither like nor dislike 5 (17.2) 7 (23.3)
 Dislike 12 (41.4) 14 (46.7)
 Dislike very much 6 (20.7) 8 (26.7)
Flavor 0.0082
 Like very much 0 0
 Like 8 (27.61) 0
 Neither like nor dislike 6 (20.7) 4 (13.3)
 Dislike 7 (24.1) 19 (63.3)
 Dislike very much 8 (27.6) 7 (23.3)
Texture 0.0090
 Like very much 1 (3.4) 0
 Like 7 (24.1) 4 (13.3)
 Neither like nor dislike 18 (62.1) 15 (50.0)
 Dislike 2 (6.9) 8 (26.7)
 Dislike very much 1 (3.4) 3 (10.0)
Overall likeability 0.0012
 Like very much 2 (6.9) 0
 Like 7 (24.1) 0
 Neither like nor dislike 9 (31.0) 6 (20.0)
 Dislike 5 (17.2) 18 (60.0)
 Dislike very much 6 (20.7) 6 (20.0)

NAC = N-acetylcysteine.

Values are presented as number (%). One subject discontinued during Period 2 without receiving the Period 2 treatment (effervescent NAC tablets).

Wilcoxon signed rank test.